Abstract
Purpose Atypical Teratoid/Rhabdoid Tumour is a rare and aggressive childhood tumour. The outcome of a series treated with the same multimodal strategy was reported. Patients The patients were treated with surgery, 2 courses of ifosfamide/carboplatin/etoposide(ICE), 2 courses of cyclophosphamide/etoposide/carboplatino/thiotepa (CECAT) or 2 other ICE courses, high dose chemotherapy (HDC) and radiotherapy. Results Eight patients underwent primary surgery achieving a complete removal in 3. Progressive disease (PD) occurred in 2/8 patients during ICE courses and in 3/4 during CECAT courses. After 4 courses 5 patients presented a PD. HDC was performed in 3 patients followed by local radiotherapy. The Kaplan Meier OS and EFS probability at 5 years are, respectively, 50% (CI 11–80%) and 33% (CI 6–66%). Conclusion A strategy based on surgery, including a second surgical look, and on radiotherapy appears the best option. ICE regimen and HDC correlate with good prognosis in some patients but this approach needs further evaluation.
Similar content being viewed by others
References
Hilden JM, Meerbaum S, Burger P et al (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22(14):2877–2884. doi:10.1200/JCO.2004.07.073
Lefkowity IB, Rorke LB, Packer RJ et al (1987) Atypical teratoid tumor of infancy: definition of an entity. Ann Neurol 22:448–449
Packer RJ, Biegel JA, Blaney S et al (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24:337–342. doi:10.1097/00043426-200206000-00004
Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumours of the nervous system. J Neuropathol Exp Neurol 61:215–225
Parwani AV, Stelow EB, Pambuccian SE et al (2005) Atypical teratoid/rhabdoid tumor of the brain: cytopathologic characteristics and differential diagnosis. Cancer 25(105):65–70. doi:10.1002/cncr.20872
Biegel JA, Fogelgren B, Zhou JY et al (2000) Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumours of the central nervous system. Clin Cancer Res 6:2759–2763
Biegel JA, Tan L, Zhang F et al (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumours and renal and extrarenal rhabdoid tumours. Clin Cancer Res 8:3461–3467
Haberler C, Laggner U, Slavc I, Czech T, Ambros I, Ambros P, Budka H, Hainfellner JA (2006) Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumours and in a fraction of primitive neuroectodermal tumours without rhabdoid phenotype. Am J Surg Pathol 30:1462–1468. doi:10.1097/01.pas.0000213329.71745.ef
Burger PC, Yu IT, Tihan T et al (1998) Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a pediatric oncology group study. Am J Surg Pathol 22:1083–1092. doi:10.1097/00000478-199809000-00007
Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumours of infancy and childhood: definition of an entity. J Neurosurg 85:56–65
Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW (2005) Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol Mar 72:77–84
Tekautz TM, Fuller CE, Blaney S et al (2005) Atypical teratoid/rhabdoid tumours (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491–1499. doi:10.1200/JCO.2005.05.187
Kaplan EL, Meier P (1959) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457–481. doi:10.2307/2281868
Reddy AT (2005) Atypical teratoid/rhabdoid tumours of the central nervous system. J Neurooncol 75:309–313. doi:10.1007/s11060-005-6762-8
Chen YW, Wong TT, Ho DM et al (2006) Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64:1038–1043. doi:10.1016/j.ijrobp.2005.10.001
Acknowledgements
The authors would like to thank G. Izzi MD who referred one patient after conventional chemotherapy and F. Giangaspero MD who reviewed the histology of the same patient. The authors would also like to thank L. Ravà PhD for statistical support and R. Trenchard PhD for editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fidani, P., De Ioris, M.A., Serra, A. et al. A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neurooncol 92, 177–183 (2009). https://doi.org/10.1007/s11060-008-9750-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-008-9750-y